Found: 6
Select item for more details and to access through your institution.
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases.
- Published in:
- PLoS Neglected Tropical Diseases, 2021, v. 15, n. 11, p. 1, doi. 10.1371/journal.pntd.0010002
- By:
- Publication type:
- Article
Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 1916, doi. 10.3390/v14091916
- By:
- Publication type:
- Article
Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow Fever and Zika Viruses Following Severe Outbreaks in Southeast Brazil.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 4, p. 364, doi. 10.3390/v12040364
- By:
- Publication type:
- Article
Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV—ANRS 12403.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 578, doi. 10.3390/vaccines12060578
- By:
- Publication type:
- Article
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
- Published in:
- Diseases, 2024, v. 12, n. 1, p. 29, doi. 10.3390/diseases12010029
- By:
- Publication type:
- Article
Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/9840210
- By:
- Publication type:
- Article